Physician profile
Kimberly E Middleton
NPI 1154864742
$5,403.14
in general payments reported to CMS, 2019-2025
28 companies · $1,457 in 2025
The $1,457 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $398 · 2022: $981 · 2023: $1,208 · 2024: $1,360 · 2025: $1,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,024.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $700.69 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $686.74 | 2021-2025 | |
| Edwards Lifesciences Corporation | $439.08 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $337.16 | 2021-2025 | Nexletol |
| Itamar Medical INC | $332.59 | 2022-2025 | Watchpatone |
| Abiomed | $328.13 | 2023-2025 | Impella |
| Amgen INC. | $256.77 | 2022-2025 | Repatha, Repatha |
| Jenavalve Technology, INC. | $256.50 | 2025 | |
| Janssen Pharmaceuticals, INC | $221.96 | 2022-2024 | Xarelto |
| Heartflow, INC. | $218.49 | 2022-2024 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.36 | 2021-2023 | Lifevest |
| Inari Medical, INC. | $192.23 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $176.45 | 2023-2024 | Resolute Onyx, Venaseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.30 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $139.43 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $116.68 | 2025 | Paradise Ultrasound Renal Denervation System |
| Astrazeneca Pharmaceuticals LP | $110.94 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $81.91 | 2021-2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $80.46 | 2024-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $75.82 | 2021-2022 | |
| Abbott Laboratories | $68.00 | 2024 | Amplatzer Amulet |
| Merck Sharp & Dohme LLC | $54.06 | 2021-2025 | Capvaxive, Verquvo |
| Lexicon Pharmaceuticals, INC. | $50.92 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $32.52 | 2025 | Attruby |
| Lilly USA, LLC | $27.46 | 2024 | Retevmo, Jaypirca, Verzenio |
| Tactile Systems Technology INC | $25.00 | 2021 | |
| Scpharmaceuticals INC. | $23.74 | 2023 | |
| Azurity Pharmaceuticals, INC. | $13.75 | 2023 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Middleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.